LHLizbeth Hu

Lizbeth Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lizbeth Hu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of Regional Anesthesia in Intensive Care: An Updated Narrative Review

    by Lizbeth Hu, Moodakare Ashwini Bhat, Kellie Marie Jaremko

    Amaç: Bu incelemenin amacı, yoğun bakım ünitesi (YBÜ) bağlamında bölgesel analjezik modalitelerinin bir özetini sunmak ve bu prosedürlerin kritik hastalarda gerçekleştirilmesinin faydaları ve sınırlamaları ile ilgili mevcut literatürü değerlendirmektir. Çalışmamızda özellikle travmatik kaburga ve ekstremite kırıkları, torasik cerrahi, majör abdominal cerrahi ve kalp cerrahisi için bölgesel teknikleri gözden geçirildi. Ayrıca, YBÜ ortamında bölgesel anestezi gerçekleştirirken klinik uygulamanın sınırlamaları da tartışıldı. Genel olarak, mevcut literatür, kritik hastalarda bölgesel analjezinin ümit verici faydalarını göstermektedir. Ancak, bu hassas popülasyon için optimum analjezik stratejileri belirlemek için daha kapsamlı, yüksek güçlü çalışmalara ihtiyaç vardır.

  • Uncomplicated epidural removal in a patient on a therapeutic heparin infusion: a case report

    by Lizbeth Hu, Janet Adegboye, Angela Tung Chang, Marie Hanna, Kellie Jaremko

    Background Unanticipated postoperative thrombotic complications can occur in complex patients who receive preoperative epidurals. Therefore, it is imperative that we consider the risks and benefits of epidural management in the setting of therapeutic anticoagulation. We present a case of epidural catheter removal on a heparin infusion, due to the extreme risk of holding anticoagulation for any duration. Case report A woman with hilar cholangiocarcinoma presented after uncomplicated hepatectomy, bile duct resection and hepaticojejunostomy, with a thoracic epidural for analgesia. On postoperative day 1, she developed a total portal vein thrombosis, requiring emergent open thrombectomy, transhepatic stenting and high-dose heparin infusion while the epidural was indwelling. The patient was deemed to have a profound risk of re-thrombosis if heparin were paused. Therefore, a multidisciplinary discussion between hepatobiliary surgery, critical care, neurosurgery, haematology, acute pain service and the patient’s family ensued regarding epidural management. Options included catheter-directed thrombolytics to her stent while holding systemic anticoagulation, sterilely leaving the epidural catheter in place indefinitely, injecting prothrombotic agent into the epidural prior to removal, or removing the catheter without holding anticoagulation. Due to the risk of re-thrombosis in the portal vein and liver infarction, the heparin infusion was decreased to achieve the lowest therapeutic anti-Xa level, and the epidural was removed. The patient was continuously monitored in the intensive care unit without any adverse events. Conclusion A multidisciplinary discussion is paramount to weigh the risk of epidural haematoma if a catheter is removed on therapeutic anticoagulation against catastrophic thrombosis if anticoagulation is paused.


  • Treatment Disparities in Hispanic Patients with Chronic Pain: An Evidence-Based Narrative Review

    by Stephanie Crimmel, Lizbeth Hu, Ryan S. D’sOuza, Eric J. Wang

    Purpose of Review The purpose of this narrative review is to summarize healthcare disparities experienced by Hispanic and Latino/Latinx patients with chronic pain, evaluate the existing literature exploring the specific therapeutic inequities affecting this patient population, and identify gaps in the literature requiring future study. Recent Findings Hispanic and Latino/Latinx patients experience disparities in chronic pain management. They are less likely to be prescribed pharmacologic therapies, including non-steroidal anti-inflammatory drugs and opioids. Hispanic and Latino/Latinx patients are also less likely to receive spinal cord stimulators and may be charged higher costs for them. There are no published studies specifically assessing Hispanic and Latino/Latinx patients’ utilization and outcomes from other common interventional pain procedures (e.g., epidural steroid injections, radiofrequency ablation). Limited data suggest non-pharmacologic treatments, such as cognitive behavioral therapy and complementary/integrative health modalities, might have more benefit for this population, potentially because of greater utilization. Summary Hispanic and Latino/Latinx patients experience disparities in chronic pain management. There is a paucity of data available pertaining specifically to pain-related outcomes and the utilization of pain treatment modalities, especially in regard to interventional procedures. Additional research is urgently needed in order to understand the full extent of these disparities and develop solutions to provide more equitable care.


  • Sleep as a Therapeutic Target for Pain Management

    by Lizbeth Hu, Eric Jyun-Han Wang

    Purpose of Review The purpose of this review is to provide a summary of the utilization of sleep as a therapeutic target for chronic pain and to evaluate the recent literature on current and proposed pharmacologic and non-pharmacologic sleep interventions used in the management of pain disorders. Recent Findings Sleep is a promising therapeutic target in the treatment of pain disorders with both non-pharmacologic and pharmacologic therapies. Non-pharmacologic therapies include cognitive behavioral therapy and sensory-based therapies such as pink noise, audio-visual stimulation, and morning bright light therapy. Pharmacologic therapies include melatonin, z-drugs, gabapentinoids, and the novel orexin antagonists. However, more research is needed to clarify if these therapies can improve pain specifically by improving sleep. Summary There is a vast array of investigational opportunities in sleep-targeted therapies for pathologic pain, and larger controlled, prospective trials are needed to fully elucidate their efficacy.